What does this research mean for the field?

Anthropometric and biochemical biomarkers reveal region-specific cardiometabolic risk features for early cardiovascular risk stratification in hypertensive patients in Kazakhstan. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

March 3, 2026

Biomarkers of Cardiometabolic Risk in Patients With Arterial Hypertension: A Cross-Sectional Pilot Study.

Key Result

Anthropometric and biochemical biomarkers in hypertensive patients reveal region-specific cardiometabolic risk features in Kazakhstan, needing larger studies.

Key Points

Elevated cardiometabolic risk markers were detected in patients with arterial hypertension, underscoring the need for targeted assessments.
Significant biomarkers related to cardiovascular risk were identified through anthropometric and biochemical evaluations.
Cross-sectional analysis provided important insights into region-specific features of cardiometabolic risk in Kazakhstan.
Findings highlight the importance of larger cohort studies for validating these observed trends and enhancing risk assessments.

Structured PICO

Population

Patients with arterial hypertension in Kazakhstan

Outcome

Cardiometabolic risk stratification using anthropometric and biochemical biomarkerssurrogate

Comprehensive assessment of anthropometric and biochemical biomarkers may aid in early cardiovascular risk stratification for hypertensive patients in Kazakhstan.

Main Result

Absolute Event Rate: 0% vs 0%

Abstract

Comprehensive assessment of anthropometric and biochemical biomarkers may be useful for early cardiovascular risk stratification in patients with arterial hypertension in Kazakhstan. The observed tendencies highlight potential region-specific features of cardiometabolic risk, warranting further investigation in larger cohorts.

Bookmark